|
Dr. Ziwei Liang Taiyuan University of Technology, Department of Biomedical Engineering, Taiyuan 030024, PR China. E-mail: Liangziweiguozhong@163.com Website: http://tylgswyxgc.tyut.edu.cn/info/1049/1681.htm |
Education
2010-2014 |
Taiyuan Normal University, China |
Biological Sciences |
Bachelor |
2014-2017 |
Sichuan University, China |
Cell biology |
Master |
2017-2020 |
Fudan University, China |
Biochemistry and Molecular Biology |
Ph.D. |
Professional Experience
2020.07- Present |
Taiyuan University of Technology, China |
Research interests
l Tumor-Targeted Therapy
l Post-Translational Modifications
l Cancer Stem Cell
l Functional Biomedical Materials
Selected publications
1. Ziwei Liang, Yanfang Yang, Yu He, Pengbo Yang, Xixi Wang, Gu He, Peng Zhang, Hongxia Zhu, Ningzhi Xu, Xia Zhao, Shufang Liang*. SUMOylation of IQGAP1 promotes the development of colorectal cancer. Cancer Lett. 2017, 411:90-99.
2. Yuanyan Wei＃, Danfang Shi＃, Ziwei Liang＃, Yuming Liu＃, Yinan Li, Yang Xing, Weitao Liu, Zhilong Ai, Jianhui Zhuang, Xiaoning Chen, Qiang Gao, Jianhai Jiang* IL-17A Secreted from Lymphatic Endothelial Cells Promotes Tumorigenesis by Up-regulation of PD-L1 in Hepatoma Stem Cells. Journal of Hepatology . 2019, 71(6): 1206-1215.
3. Yanfang Yang＃, Ziwei Liang＃, Zijing Xia, Xixi Wang, Yanni Ma, Zenghua Sheng, Qingjia Gu, GuoboShen, Liangxue Zhou, Hongxia Zhu, Ningzhi Xu, Shufang Liang*. SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways. Cell Commun. Signal. 2019,17:82.
